CareDx, Inc. Hits New 52-Week High of $40.46, Up 166%

CareDx, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 40.46 on July 17, 2026. This achievement underscores the company's robust performance, with a remarkable 1-year growth of 166.29%, significantly outpacing the S&P 500's 18.43% return during the same period. The company's financial metrics reflect a strong operational performance, highlighted by an impressive 426.01% increase in operating profit reported on March 26. CareDx has consistently delivered positive results over the last three consecutive quarters, showcasing its ability to generate substantial operating cash flow, which peaked at USD 72.95 million. Additionally, the pre-tax profit for the most recent quarter reached USD 3.38 million, marking a growth of 204.24%, while net profit also saw a significant increase of 203.07% to USD 3.41 million. With a market capitalization of USD 859 million and high institutional holdings at 100%, CareDx, Inc. continues to demonstrate strong market performance, making it a noteworthy entity in the biotechnology landscape.